pubmed-article:20673591 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20673591 | lifeskim:mentions | umls-concept:C0206178 | lld:lifeskim |
pubmed-article:20673591 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
pubmed-article:20673591 | lifeskim:mentions | umls-concept:C0681698 | lld:lifeskim |
pubmed-article:20673591 | lifeskim:mentions | umls-concept:C1414461 | lld:lifeskim |
pubmed-article:20673591 | lifeskim:mentions | umls-concept:C0887947 | lld:lifeskim |
pubmed-article:20673591 | lifeskim:mentions | umls-concept:C0750729 | lld:lifeskim |
pubmed-article:20673591 | pubmed:issue | 11 | lld:pubmed |
pubmed-article:20673591 | pubmed:dateCreated | 2010-10-25 | lld:pubmed |
pubmed-article:20673591 | pubmed:abstractText | To describe the 5-year outcomes of patients with cytomegalovirus (CMV) retinitis and AIDS in the era of highly active antiretroviral therapy (HAART). | lld:pubmed |
pubmed-article:20673591 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20673591 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20673591 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20673591 | pubmed:language | eng | lld:pubmed |
pubmed-article:20673591 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20673591 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:20673591 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:20673591 | pubmed:month | Nov | lld:pubmed |
pubmed-article:20673591 | pubmed:issn | 1549-4713 | lld:pubmed |
pubmed-article:20673591 | pubmed:author | pubmed-author:JabsDouglas... | lld:pubmed |
pubmed-article:20673591 | pubmed:author | pubmed-author:Van... | lld:pubmed |
pubmed-article:20673591 | pubmed:author | pubmed-author:AhujaAlkaA | lld:pubmed |
pubmed-article:20673591 | pubmed:author | pubmed-author:SrivastavaSun... | lld:pubmed |
pubmed-article:20673591 | pubmed:author | pubmed-author:GangaputraSap... | lld:pubmed |
pubmed-article:20673591 | pubmed:author | pubmed-author:Studies of... | lld:pubmed |
pubmed-article:20673591 | pubmed:author | pubmed-author:LyonAliceA | lld:pubmed |
pubmed-article:20673591 | pubmed:copyrightInfo | Copyright © 2010 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved. | lld:pubmed |
pubmed-article:20673591 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:20673591 | pubmed:volume | 117 | lld:pubmed |
pubmed-article:20673591 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20673591 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20673591 | pubmed:pagination | 2152-61.e1-2 | lld:pubmed |
pubmed-article:20673591 | pubmed:dateRevised | 2011-11-1 | lld:pubmed |
pubmed-article:20673591 | pubmed:meshHeading | pubmed-meshheading:20673591... | lld:pubmed |
pubmed-article:20673591 | pubmed:meshHeading | pubmed-meshheading:20673591... | lld:pubmed |
pubmed-article:20673591 | pubmed:meshHeading | pubmed-meshheading:20673591... | lld:pubmed |
pubmed-article:20673591 | pubmed:meshHeading | pubmed-meshheading:20673591... | lld:pubmed |
pubmed-article:20673591 | pubmed:meshHeading | pubmed-meshheading:20673591... | lld:pubmed |
pubmed-article:20673591 | pubmed:meshHeading | pubmed-meshheading:20673591... | lld:pubmed |
pubmed-article:20673591 | pubmed:meshHeading | pubmed-meshheading:20673591... | lld:pubmed |
pubmed-article:20673591 | pubmed:meshHeading | pubmed-meshheading:20673591... | lld:pubmed |
pubmed-article:20673591 | pubmed:meshHeading | pubmed-meshheading:20673591... | lld:pubmed |
pubmed-article:20673591 | pubmed:meshHeading | pubmed-meshheading:20673591... | lld:pubmed |
pubmed-article:20673591 | pubmed:meshHeading | pubmed-meshheading:20673591... | lld:pubmed |
pubmed-article:20673591 | pubmed:meshHeading | pubmed-meshheading:20673591... | lld:pubmed |
pubmed-article:20673591 | pubmed:meshHeading | pubmed-meshheading:20673591... | lld:pubmed |
pubmed-article:20673591 | pubmed:meshHeading | pubmed-meshheading:20673591... | lld:pubmed |
pubmed-article:20673591 | pubmed:meshHeading | pubmed-meshheading:20673591... | lld:pubmed |
pubmed-article:20673591 | pubmed:meshHeading | pubmed-meshheading:20673591... | lld:pubmed |
pubmed-article:20673591 | pubmed:meshHeading | pubmed-meshheading:20673591... | lld:pubmed |
pubmed-article:20673591 | pubmed:meshHeading | pubmed-meshheading:20673591... | lld:pubmed |
pubmed-article:20673591 | pubmed:meshHeading | pubmed-meshheading:20673591... | lld:pubmed |
pubmed-article:20673591 | pubmed:meshHeading | pubmed-meshheading:20673591... | lld:pubmed |
pubmed-article:20673591 | pubmed:meshHeading | pubmed-meshheading:20673591... | lld:pubmed |
pubmed-article:20673591 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:20673591 | pubmed:articleTitle | Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: five-year outcomes. | lld:pubmed |
pubmed-article:20673591 | pubmed:affiliation | Department of Ophthalmology, the Mount Sinai School of Medicine, New York, New York, USA. douglas.jabs@mssm.edu | lld:pubmed |
pubmed-article:20673591 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:20673591 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:20673591 | pubmed:publicationType | Multicenter Study | lld:pubmed |
pubmed-article:20673591 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |